Price is the Main Barrier to Wider Use of Papillomavirus Vaccine

At its debut 2 years ago, a vaccine that pre-vents cervical cancer was heralded as a public health breakthrough that could poten-tially save millions of women’s lives. Yet although the vaccine is now given routinely to young girls in the United States and Europe, it hasn’t been deployed in poorer countries, where it could make a bigger difference.

Pneumococcus Must be Included in the Conjugate Vaccination Scheme

Prof. Dr. Ciro A. de Quadros, co-chairman of the Pneumococcal Awareness Council of Experts (PACE), stated that there are seven children dying from diseases caused by pneumococcus bacteria every minute, pointing out that the pneumococcal conjugate vaccination was effective and safe in preventing such diseases.

Asking for increased awareness of pneumococcal infections, experts warn: ‘Pneumococcal vaccine should be covered by social health insurance’

ISTANBUL — Having convened in the 3rd Regional Pneumococcal Symposium held in Istanbul, experts lamented the low pneumococcal awareness level and called for the pneumococcal vaccine to be covered by social health insurance. Speaking at the press conference, Prof. Dr. Mehmet Ceyhan, Chairman of Turkish Association of Infectious Diseases, said that “Treatment of disease is not enough alone.

Pages